Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H24N2O4 |
| Molecular Weight | 344.4049 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C[C@@H](C)NC[C@@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1
InChI
InChIKey=BPZSYCZIITTYBL-BFUOFWGJSA-N
InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t13-,19-/m1/s1
| Molecular Formula | C19H24N2O4 |
| Molecular Weight | 344.4049 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Economic evaluation of BDP/formoterol fixed vs two single inhalers in asthma treatment. | 2010-09 |
|
| Mitochondrial respiratory chain dysfunction in dorsal root ganglia of streptozotocin-induced diabetic rats and its correction by insulin treatment. | 2010-04 |
|
| Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag--implications for research into amyotrophic lateral sclerosis (ALS). | 2010-03-08 |
|
| Antioxidant enzymes and lipid peroxidation in endometrium of patients with polyps, myoma, hyperplasia and adenocarcinoma. | 2009-12-23 |
|
| The synthetic inhibitor of fibroblast growth factor receptor PD166866 controls negatively the growth of tumor cells in culture. | 2009-12-11 |
|
| Effects of chromium picolinate on glycemic control and kidney of the obese Zucker rat. | 2009-12-10 |
|
| Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease. | 2009-11 |
|
| Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A--medical results. | 2009-10-23 |
|
| Human papillomavirus-16 E7 interacts with glutathione S-transferase P1 and enhances its role in cell survival. | 2009-10-13 |
|
| Freeze-dried strawberry powder improves lipid profile and lipid peroxidation in women with metabolic syndrome: baseline and post intervention effects. | 2009-09-28 |
|
| Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death. | 2009-09-01 |
|
| Use of formoterol in the treatment of stuttering. A pilot study. | 2009-09 |
|
| Basic study on active changes in biological function of mouse liver graft in cold storage after low-dose x-irradiation. | 2009-09 |
|
| Reduction of lipoxidative load by secretory phospholipase A2 inhibition protects against neurovascular injury following experimental stroke in rat. | 2009-08-13 |
|
| Dimethylarginine dimethylaminohydrolase in rat penile tissue: reduced enzyme activity is responsible for erectile dysfunction in a rat model of atherosclerosis. | 2009-07-16 |
|
| Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. | 2009-06-18 |
|
| Beneficial Effects of Fermented Green Tea Extract in a Rat Model of Non-alcoholic Steatohepatitis. | 2009-05 |
|
| Inhaled corticosteroid therapy for patients with persistent asthma: learnings from studies of inhaled budesonide. | 2009-04-07 |
|
| Methodological challenges in online trials. | 2009-04-03 |
|
| In vitro deposition properties of nebulized formoterol fumarate: effect of nebulization time, airflow, volume of fill and nebulizer type. | 2009-04 |
|
| IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation. | 2009-03-02 |
|
| Nebulized formoterol effect on bronchodilation and satisfaction in COPD patients compared to QID ipratropium/albuterol MDI. | 2009-03 |
|
| Spray drying of budesonide, formoterol fumarate and their composites-II. Statistical factorial design and in vitro deposition properties. | 2009-02-09 |
|
| Spray drying of budesonide, formoterol fumarate and their composites--I. Physicochemical characterisation. | 2009-02-09 |
|
| Hyperbaric oxygen treatment improves GFR in rats with ischaemia/reperfusion renal injury: a possible role for the antioxidant/oxidant balance in the ischaemic kidney. | 2009-02 |
|
| [The effect of tobacco smoking on nitric oxide serum concentration in pregnant women and umbilical cord blood]. | 2009 |
|
| LAS0811: from combinatorial chemistry to activation of antioxidant response element. | 2009 |
|
| Ceruloplasmin and superoxide dismutase (SOD1) in heterozygotes for Wilson disease: A case control study. | 2009 |
|
| Probiotics prevent intestinal barrier dysfunction in acute pancreatitis in rats via induction of ileal mucosal glutathione biosynthesis. | 2009 |
|
| Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse. | 2008-10-24 |
|
| Equivalence of a single saline nebulised dose of formoterol powder vs three doses of nebulised Albuterol every twenty minutes in acute asthma in children: a suitable cost effective approach for developing nations. | 2008-10-22 |
|
| Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions. | 2008-10 |
|
| Nebulized formoterol fumarate: Dose selection and pharmacokinetics. | 2008-10 |
|
| Long-term safety of nebulized formoterol: results of a twelve-month open-label clinical trial. | 2008-08 |
|
| Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all? | 2008-08 |
|
| Mitogenic and functional responses by nicotine and hydrogen peroxide in AR42J cells: a comparative study. | 2008-07-31 |
|
| No Different Sensitivity in Terms of Whole-Body Irradiation between Normal and Acatalasemic Mice. | 2008-07 |
|
| RAGE and modulation of ischemic injury in the diabetic myocardium. | 2008-07 |
|
| Short inhalation exposures of the isolated and perfused rat lung to respirable dry particle aerosols; the detailed pharmacokinetics of budesonide, formoterol, and terbutaline. | 2008-06 |
|
| Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. | 2008-05 |
|
| Formoterol fumarate and roxithromycin effects on muscle mass in an animal model of cancer cachexia. | 2008-05 |
|
| Increased mitochondrial DNA damage and down-regulation of DNA repair enzymes in aged rodent retinal pigment epithelium and choroid. | 2008-04-04 |
|
| New approaches to managing asthma: a US perspective. | 2008-04 |
|
| Effect of 17beta-estradiol on olfactory bulbectomy-induced oxidative stress and behavioral changes in rats. | 2008-04 |
|
| Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial. | 2008-04 |
|
| Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients. | 2008-02 |
|
| Formoterol fumarate inhalation powder vs albuterol nebulizer for the treatment of asthma in the acute care setting. | 2008-02 |
|
| The role of particulate matter-associated zinc in cardiac injury in rats. | 2008-01 |
|
| Effect of Docosahexaenoic Acid Ingestion on Temporal Change in Urinary Excretion of Mercapturic Acid in ODS Rats. | 2007-11 |
|
| Total antioxidant status and 8-hydroxy-2'-deoxyguanosine levels in gingival and peripheral blood of periodontitis patients. | 2007-03-07 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:30:50 GMT 2025
by
admin
on
Mon Mar 31 21:30:50 GMT 2025
|
| Record UNII |
ZP145530CI
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9862958
Created by
admin on Mon Mar 31 21:30:50 GMT 2025 , Edited by admin on Mon Mar 31 21:30:50 GMT 2025
|
PRIMARY | |||
|
67346-50-3
Created by
admin on Mon Mar 31 21:30:50 GMT 2025 , Edited by admin on Mon Mar 31 21:30:50 GMT 2025
|
PRIMARY | |||
|
DTXSID90217701
Created by
admin on Mon Mar 31 21:30:50 GMT 2025 , Edited by admin on Mon Mar 31 21:30:50 GMT 2025
|
PRIMARY | |||
|
ZP145530CI
Created by
admin on Mon Mar 31 21:30:50 GMT 2025 , Edited by admin on Mon Mar 31 21:30:50 GMT 2025
|
PRIMARY |